Multiple Assemblies exist for SMTL entry 3mss
Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate site; X-RAY DIFFRACTION 1.95 Å

	SMTL ID 3mss.1 Ligands 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; O-benzyl-N-methyl-L-tyrosinamide Polypeptides Tyrosine-protein kinase ABL1 Oligo-state monomer
	SMTL ID 3mss.2 Ligands 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; O-benzyl-N-methyl-L-tyrosinamide Polypeptides Tyrosine-protein kinase ABL1 Oligo-state monomer
	SMTL ID 3mss.3 Ligands 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; O-benzyl-N-methyl-L-tyrosinamide Polypeptides Tyrosine-protein kinase ABL1 Oligo-state monomer
	SMTL ID 3mss.4 Ligands 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; O-benzyl-N-methyl-L-tyrosinamide Polypeptides Tyrosine-protein kinase ABL1 Oligo-state monomer